Arcus Biosciences
Latest round
- Series C
Last raised
- Nov 2017
Total raised
- $227M
Investors
- 17
About Arcus Biosciences
Founded in 2015 and based in California, US, Arcus Biosciences, Inc. is a biotechnology company that develops immunotherapies for the treatment of cancer. In January 2024, Gilead Sciences, Inc. acquired Arcus Biosciences, Inc.00 per share. Arcus Biosciences has a robust pipeline of clinical candidates targeting various biological pathways critical to cancer progression. These include Anti-TIGIT (domvanalimab), Adenosine Axis (etrumadenant, quemliclustat), Anti-PD-1 (zimberelimab), HIF-2? Inhibitor (casdatifan), Anti-CD39 (AB598), and AXL Inhibitor (AB801). These candidates are designed to address high unmet medical needs across multiple cancer types, such as lung, gastrointestinal, kidney, pancreatic, and colorectal cancers. The company's development approach is moving from program initiation to investigational new drug (IND) filing in record time, and progressing rapidly through clinical phases. The January 2024 acquisition will allow Arcus to concentrate on developing several pipeline assets, including both Gilead-optioned and non-optioned initiatives, while also assisting Gilead Sciences, Inc. in expediting the domvanalimab program.
Who invested in Arcus Biosciences
17 investors across 3 rounds
See all investors in Arcus Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arcus Biosciences
Who invested in Arcus Biosciences?
Arcus Biosciences has 17 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arcus Biosciences raised?
Arcus Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Arcus Biosciences last raise money?
Arcus Biosciences's most recent round on record is a Series C, in Nov 2017.
What does Arcus Biosciences do?
Founded in 2015 and based in California, US, Arcus Biosciences, Inc.
Where is Arcus Biosciences headquartered?
Arcus Biosciences is headquartered in Hayward, US.
Which VCs invest in companies like Arcus Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Arcus Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Arcus Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.